The Cefadroxil Market analysis reveals a mature yet stable segment within the broader cephalosporin class, driven by its established efficacy against a range of Gram-positive bacterial infections, particularly those affecting the skin, soft tissue, and urinary tract. As a first-generation cephalosporin, Cefadroxil's primary market advantage lies in its oral bioavailability and...